Autor: |
Mo, Allen, Chung, Julie, Eichler, Jeremy, Yukelis, Sarah, Feldman, Sheldon, Fox, Jana, Garg, Madhur, Kalnicki, Shalom, Ohri, Nitin, Sparano, Joseph A., Klein, Jonathan |
Předmět: |
|
Zdroj: |
Breast; Oct2021, Vol. 59, p301-307, 7p |
Abstrakt: |
To examine clinicodemographic determinants associated with breast cancer survivorship follow-up during COVID-19. We performed a retrospective, population-based cohort study including early stage (Stage I-II) breast cancer patients who underwent resection between 2006 and 2018 in a New York City hospital system. The primary outcome was oncologic follow-up prior to and during the COVID-19 pandemic. Secondary analyses compared differences in follow-up by COVID-19 case rates stratified by ZIP code. A total of 2942 patients with early-stage breast cancer were available for analysis. 1588 (54%) of patients had attended follow-up in the year prior to the COVID-19 period but failed to continue to follow-up during the pandemic, either in-person or via telemedicine. 1242 (42%) patients attended a follow-up appointment during the COVID-19 pandemic. Compared with patients who did not present for follow-up during COVID-19, patients who continued their oncologic follow-up during the pandemic were younger (p = 0.049) more likely to have received adjuvant radiation therapy (p = 0.025), and have lower household income (p = 0.031) on multivariate modeling. When patients who live in Bronx, New York, were stratified by ZIP code, there was a modest negative association (r = −0.56) between COVID-19 cases and proportion of patients who continued to follow-up during the COVID-19 period. We observed a dramatic disruption in routine breast cancer follow-up during the COVID-19 pandemic. Providers and health systems should emphasize reintegrating patients who missed appointments during COVID-19 back into regular surveillance programs to avoid significant morbidity and mortality from missed breast cancer recurrences. • A dramatic disruption in routine oncologic follow-up was observed during the COVID-19 period. • Over half of patients with breast cancer at our center did not attend routine oncologic follow-up during COVID-19. • Patients who were younger, had lower SES, and who received radiotherapy were more likely to follow-up during the pandemic. • A modest negative association was observed between local ZIP code COVID-19 infection rates and follow-up attendance rate. [ABSTRACT FROM AUTHOR] |
Databáze: |
Supplemental Index |
Externí odkaz: |
|